Nathaniel G. Butlin

Corporate Officer/Principal bei Lumiphore, Inc.

Consumer Services

Health Technology

Profil

Nathaniel G.
Butlin is currently working as the Chief Intellectual Property Officer at Lumiphore, Inc. He has an undergraduate degree from McGill University and a doctorate degree from the University of California, Davis.

Aktive Positionen von Nathaniel G. Butlin

Unternehmen	Position	Beginn
Lumiphore, Inc. Lumiphore, Inc. BiotechnologyHealth Technology Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA.	Corporate Officer/Principal	-

Alle aktiven Positionen von Nathaniel G. Butlin

Ausbildung von Nathaniel G. Butlin

McGill University	Undergraduate Degree
University of California, Davis	Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Nathaniel G. Butlin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
Lumiphore, Inc. Lumiphore, Inc. BiotechnologyHealth Technology Lumiphore, Inc. develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. The firm offers biological detection systems based on luminescent lanthanide complexes and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics. The company was founded by Stephane Petoud and Kenneth N. Raymond in 2001 and is headquartered in Berkeley, CA.	Health Technology